Ironwood [IRWD] vs Perrigo Company plc [PRGO] Detailed Stock Comparison

Ironwood Pharmaceuticals Inc.

NASDAQ
Loading...

Perrigo Company plc

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Ironwood Pharmaceuticals Inc. wins in 10 metrics, Perrigo Company plc wins in 9 metrics, with 0 ties. Ironwood Pharmaceuticals Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ironwood Pharmaceuticals Inc. Perrigo Company plc Better
P/E Ratio (TTM) 27.13 2,818.00 Ironwood Pharmaceuticals Inc.
Price-to-Book Ratio -2.35 0.55 Perrigo Company plc
Debt-to-Equity Ratio -2.28 131.16 Perrigo Company plc
PEG Ratio -0.18 0.91 Perrigo Company plc
EV/EBITDA 8.67 7.26 Perrigo Company plc
Profit Margin (TTM) 8.11% -33.51% Ironwood Pharmaceuticals Inc.
Operating Margin (TTM) 13.74% 10.20% Ironwood Pharmaceuticals Inc.
EBITDA Margin (TTM) 13.74% 10.20% Ironwood Pharmaceuticals Inc.
Return on Equity -9.17% -38.66% Ironwood Pharmaceuticals Inc.
Return on Assets (TTM) 19.85% 2.35% Ironwood Pharmaceuticals Inc.
Free Cash Flow (TTM) $127.01M $145.10M Perrigo Company plc
Dividend Yield N/A 9.92% N/A
1-Year Return 488.71% -58.76% Ironwood Pharmaceuticals Inc.
Price-to-Sales Ratio (TTM) 2.24 0.38 Perrigo Company plc
Enterprise Value $1.05B $4.93B Perrigo Company plc
EV/Revenue Ratio 3.53 1.16 Perrigo Company plc
Gross Profit Margin (TTM) N/A 32.64% N/A
Revenue per Share (TTM) $2 $31 Perrigo Company plc
Earnings per Share (Diluted) $0.15 $-10.12 Ironwood Pharmaceuticals Inc.
Beta (Stock Volatility) 0.17 0.49 Ironwood Pharmaceuticals Inc.
Short % of Float 16.61% 18.67% Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc. vs Perrigo Company plc Stock Performance Analysis

Loading Price Chart...

IRWD
PRGO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ironwood Pharmaceuticals Inc.1.10%12.16%3.07%9.50%2.79%-13.58%
Perrigo Company plc-2.64%-7.84%0.85%10.08%-16.67%-22.97%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ironwood Pharmaceuticals Inc.488.71%-66.76%-68.86%-65.27%-72.43%-62.79%
Perrigo Company plc-58.76%-68.05%-76.25%-88.79%-86.87%-34.15%

Performance & Financial Health Analysis: Ironwood Pharmaceuticals Inc. vs Perrigo Company plc

MetricIRWDPRGO
Market Information
Market Cap i$617.99M$1.61B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,783,7322,169,621
90 Day Avg. Volume i2,608,5373,503,450
Last Close$3.69$10.70
52 Week Range$0.62 - $5.78$9.23 - $28.44
% from 52W High-36.16%-62.38%
All-Time High$17.76 (Jul 09, 2018)$215.73 (Apr 06, 2015)
% from All-Time High-79.22%-95.04%
Growth Metrics
Quarterly Revenue Growth-0.47%-0.03%
Quarterly Earnings Growth-0.47%-0.03%
Financial Health
Profit Margin (TTM) i0.08%-0.34%
Operating Margin (TTM) i0.14%0.10%
Return on Equity (TTM) i-0.09%-0.39%
Debt to Equity (MRQ) i-2.28131.16
Cash & Liquidity
Book Value per Share (MRQ)$-1.61$21.33
Cash per Share (MRQ)$1.32$3.86
Operating Cash Flow (TTM) i$127.04M$238.50M
Levered Free Cash Flow (TTM) i$111.57M$28.33M
Dividends
Last 12-Month Dividend Yield iN/A9.92%
Last 12-Month Dividend iN/A$1.16

Valuation & Enterprise Metrics Analysis: Ironwood Pharmaceuticals Inc. vs Perrigo Company plc

MetricIRWD (Apr 24, 2026)PRGO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i27.132,818.00
Forward P/E i2.794.93
PEG Ratio i-0.180.91
Price to Sales (TTM) i2.240.38
Price to Book (MRQ) i-2.350.55
Market Capitalization
Market Capitalization i$617.99M$1.61B
Enterprise Value i$1.05B$4.93B
Enterprise Value Metrics
Enterprise to Revenue i3.531.16
Enterprise to EBITDA i8.677.26
Risk & Other Metrics
Beta i0.170.49
Book Value per Share (MRQ) i$-1.61$21.33

Financial Statements Comparison: Ironwood Pharmaceuticals Inc. vs Perrigo Company plc

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIRWD (2025)PRGO (2025)
Revenue/Sales i296.15M4.25B
Cost of Goods Sold iN/A2.76B
COGS % of Revenue i0.0%64.9%
Gross Profit iN/A1.49B
Gross Margin i0.0%35.1%
Research & Development i95.14M95.40M
Operating Income (EBIT) i118.76M312.80M
Operating Margin i40.1%7.4%
EBITDA i124.91M637.10M
EBITDA Margin i42.2%15.0%
Pre-Tax Income i70.03M-1.30B
Pre-Tax Income % of Revenue i23.6%-30.5%
Income Tax i46.01M104.40M
Income Tax % of Revenue i15.5%2.5%
Net Income (Profit) i24.02M-1.43B
Profit Margin i8.1%-33.5%

Balance Sheet & Liquidity Metrics

MetricIRWD (2025)PRGO (2025)
Cash & Equivalents i215.46M531.60M
Total Current Assets i274.18M2.80B
Total Current Assets % of Revenue i92.6%65.8%
Total Current Liabilities i242.22M1.01B
Total Current Liabilities % of Revenue i81.8%23.8%
Long-Term Debt i394.87M3.60B
Long-Term Debt % of Revenue i133.3%84.7%
Total Shareholders Equity i-261.84M2.94B
Retained Earnings i-1.67B-3.68B
Retained Earnings % of Revenue i-565.2%-86.5%
Property, Plant & Equipment i9.34M167.80M

Cash Flow Statement Comparison

MetricIRWD (2025)PRGO (2025)
Operating Cash Flow i130.69M-1.06B
Operating Cash Flow % of Revenue i44.1%-24.9%
Capital Expenditures i-34,000-93.40M
Free Cash Flow i127.01M145.10M
FCF Margin i42.9%3.4%
Debt Repayment i0-34.80M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricIRWDPRGO
Shares Short i17.90M16.69M
Short Ratio i5.913.99
Short % of Float i16.61%18.67%
Shares Outstanding i163.06M137.62M
Float Shares i125.58M136.81M
% Held by Insiders i3.05%0.41%
% Held by Institutions i92.07%115.48%
% Held by Public i4.88%-15.89%

Dividend Analysis & Yield Comparison: Ironwood Pharmaceuticals Inc. vs Perrigo Company plc

MetricIRWDPRGO
Last 12-Month Dividend iN/A$1.16
Last 12-Month Dividend Yield iN/A9.92%
3-Year Avg Annual Dividend iN/A$1.12
3-Year Avg Dividend Yield iN/A1.09%
3-Year Total Dividends iN/A$3.36
Ex-Dividend DateN/AMar 02, 2026